GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests​GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests 

GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests​GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests 

 Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related cancers, new research suggests.  ​​Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related cancers, new research suggests. 

Leave a Reply

Your email address will not be published. Required fields are marked *